Table 6.
N = 122 | |
---|---|
IUS insufficient/additional evaluation deemed necessary | 77 |
Baseline evaluation before starting or follow-up of biologic treatment | 13 |
Stricture dilation | 14 |
Evaluation of treatment response | 3 |
Extensive complications | 4 |
Inclusion in clinical trial | 8 |
Melaena | 1 |
Suspicion of malignancy | 2 |
IUS, intestinal ultrasound; MRI, magnetic resonance imaging; CT, computed tomography.